Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Buy
52
RIGL Quote, Financials, Valuation and Earnings
Last price:
$18.89
Seasonality move
:
5.49%
Day range:
$18.90 - $19.43
52-week range:
$8.61 - $29.82
Dividend yield:
0%
P/E ratio:
9.31x
P/S ratio:
1.69x
P/B ratio:
18.56x
Volume:
135.2K
Avg. volume:
196.6K
1-year change:
71.38%
Market cap:
$344.6M
Revenue:
$179.3M
EPS (TTM):
$2.07
Earnings Data
Next earnings date for RIGL
Aug 06
2025
Most recent earnings per share
$0.63
Beat by $0.54
(May 6/2025)
Consensus Estimate
$0.09
(May 6/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
RIGL Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | $50.6M | -- | -- | $0.24 | -- |
| 08/06/2025 | Q2 | $64.6M | -- | -- | $1.41 | -- |
| 05/06/2025 | Q1 | $43.9M | $53.3M | $0.63 | $0.09 | $0.54 |
| 03/04/2025 | Q4 | $57.6M | $57.6M | $0.80 | $0.58 | $0.22 |
| 11/07/2024 | Q3 | $41.9M | $55.3M | $0.70 | $0.06 | $0.64 |
| 08/06/2024 | Q2 | $33.7M | $36.8M | -$0.06 | -$0.18 | $0.12 |
| 05/07/2024 | Q1 | $31.5M | $29.5M | -$0.47 | -$0.27 | -$0.20 |
| 03/05/2024 | Q4 | $33.4M | $35.8M | $0.05 | -$0.24 | $0.29 |
| 11/07/2023 | Q3 | $27.2M | $28.1M | -$0.33 | -$0.66 | $0.33 |
| 08/01/2023 | Q2 | $25.7M | $26.9M | -$0.38 | -$0.80 | $0.42 |
| 05/02/2023 | Q1 | -- | $26.1M | -$0.80 | -- | -- |
| 03/07/2023 | Q4 | -- | $51.3M | $0.10 | -- | -- |
| 11/03/2022 | Q3 | -- | $22.4M | -$1.10 | -- | -- |
| 08/02/2022 | Q2 | -- | $29.8M | -$0.80 | -- | -- |
| 05/03/2022 | Q1 | -- | $16.7M | -$1.60 | -- | -- |
| 03/01/2022 | Q4 | -- | $20.4M | -$1.30 | -- | -- |
| 11/02/2021 | Q3 | -- | $21.5M | -$1.20 | -- | -- |
| 08/03/2021 | Q2 | -- | $26.3M | -$0.80 | -- | -- |
| 05/05/2021 | Q1 | -- | $81M | $2.20 | -- | -- |
| 03/02/2021 | Q4 | -- | $18.5M | -$1.10 | -- | -- |
| 11/05/2020 | Q3 | -- | $18.4M | -$0.80 | -- | -- |
| 08/04/2020 | Q2 | -- | $16M | -$1.00 | -- | -- |
| 05/05/2020 | Q1 | -- | $55.8M | $1.30 | -- | -- |
| 02/27/2020 | Q4 | -- | $15.4M | -$1.00 | -- | -- |
| 11/05/2019 | Q3 | -- | $20.9M | -$0.70 | -- | -- |
| 08/06/2019 | Q2 | -- | $10.4M | -$1.20 | -- | -- |
| 05/07/2019 | Q1 | -- | $12.6M | -$1.10 | -- | -- |
| 02/28/2019 | Q4 | -- | $37.9M | $0.20 | -- | -- |
| 11/06/2018 | Q3 | -- | $4.9M | -$1.40 | -- | -- |
| 08/08/2018 | Q2 | -- | $1.8M | -$1.60 | -- | -- |
| 05/01/2018 | Q1 | -- | -- | -$1.70 | -- | -- |
| 03/06/2018 | Q4 | -- | -- | -$1.80 | -- | -- |
| 11/01/2017 | Q3 | -- | $900K | -$1.40 | -- | -- |
| 08/01/2017 | Q2 | -- | -- | -$1.60 | -- | -- |
| 04/25/2017 | Q1 | -- | $3.6M | -$1.30 | -- | -- |
| 03/07/2017 | Q4 | -- | $3M | -$1.60 | -- | -- |
| 11/01/2016 | Q3 | -- | $3.8M | -$2.40 | -- | -- |
| 08/02/2016 | Q2 | -- | $8.6M | -$1.50 | -- | -- |
| 05/03/2016 | Q1 | -- | $5M | -$1.90 | -- | -- |
| 03/08/2016 | Q4 | -- | $8.5M | -$1.40 | -- | -- |
| 11/03/2015 | Q3 | -- | $13M | -$0.80 | -- | -- |
Rigel Pharmaceuticals Earnings Questions
-
How Much did Rigel Pharmaceuticals Generate in Revenue Last Quarter?
Rigel Pharmaceuticals reported $53.3M worth of top line sales in its most recent quarter.
-
Did Rigel Pharmaceuticals Beat Earnings Last Quarter?
Rigel Pharmaceuticals announced earnings per share of $0.63 which represents a beat of analyst forecast a $0.09 per share.
-
Is Rigel Pharmaceuticals Profitable?
Rigel Pharmaceuticals reported $48.9M that represents $2.69 per share over the last quarter.
-
What is the Analyst Consensus for Rigel Pharmaceuticals EPS Next Year?
Rigel Pharmaceuticals's earnings are forecast to grow from $0.99 per share to $0.39 per share next year representing an increase of 127.81%.
-
When is Rigel Pharmaceuticals's Earnings Date?
Rigel Pharmaceuticals's next earnings date is August 6, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
